Cambridge Investment Research Advisors
EXPO icon

Cambridge Investment Research Advisors’s Exponent EXPO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio EXPO Stock Details EXPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$289K Buy
4,437
+118
+3% +$8.39K ﹤0.01% 3318
2025
Q4 		$300K Sell
4,319
-1,983
-31% -$139K ﹤0.01% 3205
2025
Q3 		$438K Buy
6,302
+394
+7% +$28.2K ﹤0.01% 2791
2025
Q2 		$441K Buy
5,908
+72
+1% +$5.58K ﹤0.01% 2654
2025
Q1 		$473K Sell
5,836
-351
-6% -$30.6K ﹤0.01% 2495
2024
Q4 		$551K Sell
6,187
-1,247
-17% -$126K ﹤0.01% 2349
2024
Q3 		$857K Sell
7,434
-555
-7% -$58.1K ﹤0.01% 1959
2024
Q2 		$760K Sell
7,989
-2,686
-25% -$242K ﹤0.01% 1973
2024
Q1 		$883K Sell
10,675
-2,296
-18% -$190K ﹤0.01% 1811
2023
Q4 		$1.14M Sell
12,971
-2,186
-14% -$179K ﹤0.01% 1558
2023
Q3 		$1.3M Sell
15,157
-990
-6% -$89.5K 0.01% 1408
2023
Q2 		$1.51M Sell
16,147
-352
-2% -$33.1K 0.01% 1341
2023
Q1 		$1.65M Buy
16,499
+11
+0.1% +$1.12K 0.01% 1239
2022
Q4 		$1.63M Buy
16,488
+293
+2% +$28.5K 0.01% 1194
2022
Q3 		$1.42M Buy
16,195
+569
+4% +$53.9K 0.01% 1253
2022
Q2 		$1.43M Buy
15,626
+374
+2% +$35.2K 0.01% 1228
2022
Q1 		$1.65M Buy
15,252
+356
+2% +$34.3K 0.01% 1257
2021
Q4 		$1.74M Buy
14,896
+1,113
+8% +$131K 0.01% 1226
2021
Q3 		$1.56M Buy
13,783
+405
+3% +$43.7K 0.01% 1233
2021
Q2 		$1.19M Buy
13,378
+387
+3% +$36.2K 0.01% 1408
2021
Q1 		$1.27M Buy
12,991
+258
+2% +$24.2K 0.01% 1275
2020
Q4 		$1.15M Buy
12,733
+587
+5% +$46.8K 0.01% 1214
2020
Q3 		$875K Buy
12,146
+668
+6% +$53.1K 0.01% 1262
2020
Q2 		$929K Buy
11,478
+1,291
+13% +$92.9K 0.01% 1161
2020
Q1 		$733K Buy
10,187
+2,191
+27% +$159K 0.01% 1141
2019
Q4 		$552K Sell
7,996
-30
-0.4% -$1.98K ﹤0.01% 1515
2019
Q3 		$561K Buy
8,026
+312
+4% +$21.1K ﹤0.01% 1426
2019
Q2 		$452K Sell
7,714
-527
-6% -$30K ﹤0.01% 1494
2019
Q1 		$476K Sell
8,241
-2,951
-26% -$159K ﹤0.01% 1511
2018
Q4 		$568K Sell
11,192
-22
-0.2% -$1.1K 0.01% 1243
2018
Q3 		$601K Buy
11,214
+449
+4% +$23K 0.01% 1340
2018
Q2 		$520K Sell
10,765
-337
-3% -$15.5K 0.01% 1376
2018
Q1 		$437K Buy
11,102
+550
+5% +$20.8K ﹤0.01% 1424
2017
Q4 		$375K Sell
10,552
-32
-0.3% -$1.18K ﹤0.01% 1491
2017
Q3 		$391K Buy
10,584
+344
+3% +$11.4K 0.01% 1386
2017
Q2 		$298K Sell
10,240
-226
-2% -$6.75K ﹤0.01% 1515
2017
Q1 		$312K Buy
10,466
+588
+6% +$17.1K 0.01% 1349
2016
Q4 		$298K Buy
9,878
+174
+2% +$5.05K 0.01% 1271
2016
Q3 		$248K Buy
+9,704
New +$253K ﹤0.01% 1413

Other funds holding EXPO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cambridge Investment Research Advisors's EXPO Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its Exponent (EXPO) stake by 2.7% in Q1 2026, buying an estimated $8.39K and bringing the position to 4,437 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #3318.

Cambridge Investment Research Advisors first reported a position in EXPO in Q3 2016 and has held it in 39 quarters since. The position peaked at $1.74M in Q4 2021. 360 funds tracked by Wall St. Rank hold EXPO as of Q1 2026.

  • Cambridge Investment Research Advisors held 4,437 shares of Exponent worth $289K as of Q1 2026.
  • Cambridge Investment Research Advisors bought 118 Exponent shares in Q1 2026, an estimated $8.39K.
  • Exponent made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #3318 holding.
  • Cambridge Investment Research Advisors first reported a position in Exponent in Q3 2016 and has held it in 39 quarters since.
  • Cambridge Investment Research Advisors's Exponent position peaked at $1.74M in Q4 2021.
  • 360 funds tracked by Wall St. Rank held Exponent as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.